195 related articles for article (PubMed ID: 18622636)
1. Comparative activities of daidzein metabolites, equol and O-desmethylangolensin, on bone mineral density and lipid metabolism in ovariectomized mice and in osteoclast cell cultures.
Ohtomo T; Uehara M; Peñalvo JL; Adlercreutz H; Katsumata S; Suzuki K; Takeda K; Masuyama R; Ishimi Y
Eur J Nutr; 2008 Aug; 47(5):273-9. PubMed ID: 18622636
[TBL] [Abstract][Full Text] [Related]
2. Equol, a metabolite of daidzein, inhibits bone loss in ovariectomized mice.
Fujioka M; Uehara M; Wu J; Adlercreutz H; Suzuki K; Kanazawa K; Takeda K; Yamada K; Ishimi Y
J Nutr; 2004 Oct; 134(10):2623-7. PubMed ID: 15465757
[TBL] [Abstract][Full Text] [Related]
3. Kanamycin inhibits daidzein metabolism and abilities of the metabolites to prevent bone loss in ovariectomized mice.
Katsumata S; Fujioka M; Fujii S; Takeda K; Ishimi Y; Uehara M
BMC Res Notes; 2016 Jul; 9():334. PubMed ID: 27388904
[TBL] [Abstract][Full Text] [Related]
4. (S)-Equol Is More Effective than (R)-Equol in Inhibiting Osteoclast Formation and Enhancing Osteoclast Apoptosis, and Reduces Estrogen Deficiency-Induced Bone Loss in Mice.
Tanaka M; Fujii S; Inoue H; Takahashi N; Ishimi Y; Uehara M
J Nutr; 2022 Aug; 152(8):1831-1842. PubMed ID: 35675296
[TBL] [Abstract][Full Text] [Related]
5. Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol.
Mathey J; Mardon J; Fokialakis N; Puel C; Kati-Coulibaly S; Mitakou S; Bennetau-Pelissero C; Lamothe V; Davicco MJ; Lebecque P; Horcajada MN; Coxam V
Osteoporos Int; 2007 May; 18(5):671-9. PubMed ID: 17333448
[TBL] [Abstract][Full Text] [Related]
6. The combined effects of soya isoflavones and resistant starch on equol production and trabecular bone loss in ovariectomised mice.
Tousen Y; Matsumoto Y; Matsumoto C; Nishide Y; Nagahata Y; Kobayashi I; Ishimi Y
Br J Nutr; 2016 Jul; 116(2):247-57. PubMed ID: 27197747
[TBL] [Abstract][Full Text] [Related]
7. Resistant starch promotes equol production and inhibits tibial bone loss in ovariectomized mice treated with daidzein.
Tousen Y; Abe F; Ishida T; Uehara M; Ishimi Y
Metabolism; 2011 Oct; 60(10):1425-32. PubMed ID: 21550090
[TBL] [Abstract][Full Text] [Related]
8. Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes.
Frankenfeld CL; McTiernan A; Thomas WK; LaCroix K; McVarish L; Holt VL; Schwartz SM; Lampe JW
Maturitas; 2006 Feb; 53(3):315-24. PubMed ID: 16019168
[TBL] [Abstract][Full Text] [Related]
9. A combination of dietary fructooligosaccharides and isoflavone conjugates increases femoral bone mineral density and equol production in ovariectomized mice.
Ohta A; Uehara M; Sakai K; Takasaki M; Adlercreutz H; Morohashi T; Ishimi Y
J Nutr; 2002 Jul; 132(7):2048-54. PubMed ID: 12097691
[TBL] [Abstract][Full Text] [Related]
10. Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice.
Fonseca D; Ward WE
Bone; 2004 Aug; 35(2):489-97. PubMed ID: 15268901
[TBL] [Abstract][Full Text] [Related]
11. Supplemental dietary racemic equol has modest benefits to bone but has mild uterotropic activity in ovariectomized rats.
Legette LL; Martin BR; Shahnazari M; Lee WH; Helferich WG; Qian J; Waters DJ; Arabshahi A; Barnes S; Welch J; Bostwick DG; Weaver CM
J Nutr; 2009 Oct; 139(10):1908-13. PubMed ID: 19710157
[TBL] [Abstract][Full Text] [Related]
12. Effects of daidzein and kiwifruit on bone mineral density and equol production in ovariectomised rats.
Tousen Y; Wolber FM; Chua WH; Tadaishi M; Ishimi Y; Kruger MC
Int J Food Sci Nutr; 2014 May; 65(3):360-7. PubMed ID: 24251973
[TBL] [Abstract][Full Text] [Related]
13. Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial.
Wu J; Oka J; Higuchi M; Tabata I; Toda T; Fujioka M; Fuku N; Teramoto T; Okuhira T; Ueno T; Uchiyama S; Urata K; Yamada K; Ishimi Y
Metabolism; 2006 Apr; 55(4):423-33. PubMed ID: 16546471
[TBL] [Abstract][Full Text] [Related]
14. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health.
Atkinson C; Frankenfeld CL; Lampe JW
Exp Biol Med (Maywood); 2005 Mar; 230(3):155-70. PubMed ID: 15734719
[TBL] [Abstract][Full Text] [Related]
15. Combined intervention of soy isoflavone and moderate exercise prevents body fat elevation and bone loss in ovariectomized mice.
Wu J; Wang X; Chiba H; Higuchi M; Nakatani T; Ezaki O; Cui H; Yamada K; Ishimi Y
Metabolism; 2004 Jul; 53(7):942-8. PubMed ID: 15254891
[TBL] [Abstract][Full Text] [Related]
16. A combination of soy isoflavones and cello-oligosaccharides changes equol/O-desmethylangolensin production ratio and attenuates bone fragility in ovariectomized mice.
Fujii S; Takahashi N; Inoue H; Katsumata S; Kikkawa Y; Machida M; Ishimi Y; Uehara M
Biosci Biotechnol Biochem; 2016 Aug; 80(8):1632-5. PubMed ID: 27191709
[TBL] [Abstract][Full Text] [Related]
17. Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency.
Ishimi Y; Miyaura C; Ohmura M; Onoe Y; Sato T; Uchiyama Y; Ito M; Wang X; Suda T; Ikegami S
Endocrinology; 1999 Apr; 140(4):1893-900. PubMed ID: 10098529
[TBL] [Abstract][Full Text] [Related]
18. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro.
Yuan SY; Sheng T; Liu LQ; Zhang YL; Liu XM; Ma T; Zheng H; Yan Y; Ishimi Y; Wang XX
Chin J Nat Med; 2016 Apr; 14(4):265-269. PubMed ID: 27114313
[TBL] [Abstract][Full Text] [Related]
19. Detection of isoflavones in mouse tibia after feeding daidzein.
Fonseca D; Ward WE
J Med Food; 2006; 9(3):436-9. PubMed ID: 17004913
[TBL] [Abstract][Full Text] [Related]
20. Effect of daidzein, a soy isoflavone, on bone metabolism in Cd-treated ovariectomized rats.
Om AS; Shim JY
Acta Biochim Pol; 2007; 54(3):641-6. PubMed ID: 17717607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
